Processing

Please wait...

Settings

Settings

1. WO2020000059 - INFLAMMATORY SKIN DISORDER TREATMENT

Publication Number WO/2020/000059
Publication Date 02.01.2020
International Application No. PCT/AU2019/050691
International Filing Date 28.06.2019
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
04
Linear peptides containing only normal peptide links
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
04
Linear peptides containing only normal peptide links
08
having 12 to 20 amino acids
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
705
Receptors; Cell surface antigens; Cell surface determinants
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
06
Ointments; Bases therefor
A61K 38/04 (2006.01)
A61K 38/17 (2006.01)
C07K 7/04 (2006.01)
C07K 7/08 (2006.01)
C07K 14/705 (2006.01)
A61P 17/00 (2006.01)
CPC
A61K 38/04
A61K 38/07
A61K 38/08
A61K 38/10
A61K 38/17
A61K 38/177
Applicants
  • NOVAPEP PTY LTD [AU/AU]; 234 George Street Sydney, New South Wales 2000, AU
Inventors
  • JACKSON, Christopher John; AU
  • XUE, Meilang; AU
Agents
  • FPA PATENT ATTORNEYS PTY LTD; Level 43 101 Collins Street Melbourne, Victoria 3000, AU
Priority Data
62/691,51228.06.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) INFLAMMATORY SKIN DISORDER TREATMENT
(FR) TRAITEMENT DE TROUBLES CUTANÉS INFLAMMATOIRES
Abstract
(EN)
The invention relates to a method of minimising a symptom of dermatitis in an individual having a skin disease or condition comprising the administration of a TR47 related peptide, wherein the TR47 related peptide generally refers to a peptide having an N-terminal sequence NH2-NPND or NH2-NPNDKY, which is derived from the N-terminal sequence of the Met1-Arg46 deleted human PAR1 (protease activated receptor 1) sequence.
(FR)
L'invention concerne un procédé pour réduire au maximum un symptôme de dermatite chez un individu ayant une maladie ou une affection cutanée comprenant l'administration d'un peptide lié à TR47, le peptide lié à TR47 se référant de manière générale à un peptide ayant une séquence N-terminale NH2-NPND ou NH2-NPNDKY, qui est dérivée de la séquence N-terminale de la séquence PAR1 (récepteur activé par la protéase 1) à délétion de Met1-Arg46.
Latest bibliographic data on file with the International Bureau